We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

467 hedge funds and large institutions have $6.73B invested in Bio-Rad Laboratories Class A in 2023 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 146 increasing their positions, 181 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.52% more ownership

Funds ownership: 76.74%78.26% (+1.5%)

2% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 58

0% more funds holding in top 10

Funds holding in top 10: 99 (0)

0% less funds holding

Funds holding: 468467 (-1)

7% less call options, than puts

Call options by funds: $24.6M | Put options by funds: $26.4M

6% less capital invested

Capital invested by funds: $7.19B → $6.73B (-$462M)

19% less repeat investments, than reductions

Existing positions increased: 146 | Existing positions reduced: 181

Holders
467
Holders Change
-1
Holders Change %
-0.21%
% of All Funds
7.41%
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.14%
New
59
Increased
146
Reduced
181
Closed
58
Calls
$24.6M
Puts
$26.4M
Net Calls
-$1.76M
Net Calls Change
+$23.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
476
Point72 Asset Management
Connecticut
-$27.8M -73,459 Closed
Canada Pension Plan Investment Board
477
Canada Pension Plan Investment Board
Ontario, Canada
-$26M -68,467 Closed
AAF
478
Andra AP-fonden
Sweden
-$9.36M -24,700 Closed
Voloridge Investment Management
479
Voloridge Investment Management
Florida
-$8.55M -22,557 Closed
CFM
480
Coronation Fund Managers
South Africa
-$5.71M -15,060 Closed
SIM
481
SW Investment Management
Colorado
-$5.69M -15,000 Closed
Holocene Advisors
482
Holocene Advisors
New York
-$2.93M -7,739 Closed
JF
483
Jump Financial
Illinois
-$2.85M -7,516 Closed
EWM
484
Elevatus Welath Management
New York
-$2.59M -6,821 Closed
PE
485
Point72 Europe
United Kingdom
-$2.21M -5,833 Closed
WBC
486
Westpac Banking Corp
Australia
-$1.44M -3,796 Closed
E
487
Ergoteles
New York
-$773K -2,039 Closed
TA
488
Tamarack Advisers
California
-$758K -2,000 Closed
ASN
489
Advisory Services Network
Georgia
-$728K -1,921 Closed
CAM
490
Crown Advisors Management
California
-$568K -1,500 Closed
APM
491
Advanced Portfolio Management
New York
-$502K -1,323 Closed
CCIA
492
Campbell & Co Investment Adviser
Maryland
-$499K -1,317 Closed
CM
493
Capula Management
Cayman Islands
-$485K -1,280 Closed
SG Americas Securities
494
SG Americas Securities
New York
-$438K -1,155 Closed
Renaissance Technologies
495
Renaissance Technologies
New York
-$417K -1,100 Closed
AIM
496
Achmea Investment Management
Netherlands
-$411K -1,084 Closed
CCG
497
Cypress Capital Group
Florida
-$373K -984 Closed
XT
498
XTX Topco
Cayman Islands
-$326K -860 Closed
QPW
499
Quantum Private Wealth
Florida
-$325K -856 Closed
SFA
500
Sequoia Financial Advisors
Ohio
-$325K -856 Closed

BIO Hedge Fund Activity: Q3 2023 in Review

467 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2023, worth a combined $6.73B — down 6.4% from $7.19B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new BIO positions and 58 closed out — a net gain of 1 holder — while 146 added to existing stakes and 181 trimmed.

The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $125M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $97.3M sold.

  • 467 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2023, down from 468 in Q2 2023.
  • Funds reported $6.73B of Bio-Rad Laboratories Class A stock for Q3 2023, down 6.4% quarter-over-quarter.
  • 59 funds opened new Bio-Rad Laboratories Class A positions in Q3 2023 and 58 closed out, a net change of +1 holder.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2023 was Massachusetts Financial Services, an estimated $125M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2023 was Champlain Investment Partners, an estimated $97.3M sold.

Based on aggregated 13F filings for Q3 2023.